B

OSTON — A representative of the Trump administration on Tuesday made a familiar promise to a crowd of state legislators here: We know high drug prices are a problem. And we’re working to solve it.

Lowering drug costs is a “priority,” and the Department of Health and Human Services is “committed to doing all we can to increase affordability and accessibility,” said Jane Norton, HHS’s point person in dealing with state governments.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.

X